Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Sarah Cannon | Researchclopedia

Back to institutions

Sarah Cannon

Nashville, Tennesseefacility

6,939

Works

559,311

Citations

321

h-index

Top Research Topics

Lung Cancer Treatments and Mutations Cancer Immunotherapy and Biomarkers CAR-T cell therapy research

Top Researchers

Eric J. Topol Scripps Institution of Oceanography

1,714 works179,365 citationsh-index: 202

Recent Research

Base Editing of <i>HBG1</i> and <i>HBG2</i> Promoters for Sickle Cell Disease

Ashish O. Gupta,Akshay Sharma,et al.

20263 citations

Cancer Treatment and Pharmacology

Advanced Breast Cancer Therapies

HER2/EGFR in Cancer Research

Chronic Lymphocytic Leukemia Research

Colorectal Cancer Treatments and Studies

Lung Cancer Research Studies

Lymphoma Diagnosis and Treatment

Cancer Genomics and Diagnostics

Monoclonal and Polyclonal Antibodies Research

Georgina V. Long The University of Sydney

1,822 works172,938 citationsh-index: 169

Mark A. Rubin University of Bern

1,524 works165,725 citationsh-index: 186

Antoni Ribas APLA Health

1,710 works162,010 citationsh-index: 158

Gabriel N. Hortobágyi The University of Texas MD Anderson Cancer Center

1,905 works139,590 citationsh-index: 187

Eric P. Winer Harvard University

1,618 works128,848 citationsh-index: 170

CRISPR-Cas12a Gene Editing of <i>HBG1</i> and <i>HBG2</i> Promoters to Treat β-Thalassemia

Haydar Frangoul,Rabi Hanna,et al.

20263 citations

CRISPR-Cas12a Gene Editing of <i>HBG1</i> and <i>HBG2</i> Promoters to Treat Sickle Cell Disease

Rabi Hanna,Haydar Frangoul,et al.

20263 citations

89O BMS-986504 with or without gemcitabine (GEM) + nab-paclitaxel (nab-P) in patients (pts) with pancreatic ductal adenocarcinoma (PDAC) and homozygous MTAP deletion (MTAP-del) from CA240-0007

B. George,Konstantinos Leventakos,et al.

20260 citations

Ifinatamab deruxtecan, a B7-H3-directed antibody–drug conjugate, in patients with advanced solid tumours (IDeate-PanTumor01): dose-escalation results from a phase 1/2 trial

Melissa L. Johnson,Manish R Patel,et al.

20261 citations

Reply: Treatment Switching and Subsequent Therapy Confound Overall Survival Estimates in PHAROS

Melissa L. Johnson

20260 citations